484 related articles for article (PubMed ID: 21699799)
1. Mouse hepatic cells support assembly of infectious hepatitis C virus particles.
Long G; Hiet MS; Windisch MP; Lee JY; Lohmann V; Bartenschlager R
Gastroenterology; 2011 Sep; 141(3):1057-66. PubMed ID: 21699799
[TBL] [Abstract][Full Text] [Related]
2. Trans-encapsidation of hepatitis C virus subgenomic replicon RNA with viral structure proteins.
Ishii K; Murakami K; Hmwe SS; Zhang B; Li J; Shirakura M; Morikawa K; Suzuki R; Miyamura T; Wakita T; Suzuki T
Biochem Biophys Res Commun; 2008 Jul; 371(3):446-50. PubMed ID: 18445476
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
[TBL] [Abstract][Full Text] [Related]
4. Permissiveness of human hepatocellular carcinoma cell lines for hepatitis C virus entry and replication.
Coto-Llerena M; Koutsoudakis G; Boix L; López-Oliva JM; Caro-Pérez N; Fernández-Carrillo C; González P; Gastaminza P; Bruix J; Forns X; Pérez-Del-Pulgar S
Virus Res; 2017 Aug; 240():35-46. PubMed ID: 28751105
[TBL] [Abstract][Full Text] [Related]
5. Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells.
Frentzen A; Anggakusuma ; Gürlevik E; Hueging K; Knocke S; Ginkel C; Brown RJ; Heim M; Dill MT; Kröger A; Kalinke U; Kaderali L; Kuehnel F; Pietschmann T
Hepatology; 2014 Jan; 59(1):78-88. PubMed ID: 23873628
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
[TBL] [Abstract][Full Text] [Related]
7. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
Jarczak D; Korf M; Beger C; Manns MP; Krüger M
FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
[TBL] [Abstract][Full Text] [Related]
8. Amphipathic α-helices in apolipoproteins are crucial to the formation of infectious hepatitis C virus particles.
Fukuhara T; Wada M; Nakamura S; Ono C; Shiokawa M; Yamamoto S; Motomura T; Okamoto T; Okuzaki D; Yamamoto M; Saito I; Wakita T; Koike K; Matsuura Y
PLoS Pathog; 2014 Dec; 10(12):e1004534. PubMed ID: 25502789
[TBL] [Abstract][Full Text] [Related]
9. In vitro replication models for the hepatitis C virus.
Sheehy P; Mullan B; Moreau I; Kenny-Walsh E; Shanahan F; Scallan M; Fanning LJ
J Viral Hepat; 2007 Jan; 14(1):2-10. PubMed ID: 17212638
[TBL] [Abstract][Full Text] [Related]
10. Packaging of HCV-RNA into lentiviral vector.
Caval V; Piver E; Ivanyi-Nagy R; Darlix JL; Pagès JC
Biochem Biophys Res Commun; 2011 Nov; 414(4):808-13. PubMed ID: 22008549
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus infection in mouse hepatoma cells co-expressing human CD81 and Sip-L.
Yeh CT; Lai HY; Yeh YJ; Cheng JC
Biochem Biophys Res Commun; 2008 Jul; 372(1):157-61. PubMed ID: 18474223
[TBL] [Abstract][Full Text] [Related]
12. Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles.
Doerrbecker J; Friesland M; Riebesehl N; Ginkel C; Behrendt P; Brown RJ; Ciesek S; Wedemeyer H; Sarrazin C; Kaderali L; Pietschmann T; Steinmann E
Hepatology; 2014 Aug; 60(2):508-20. PubMed ID: 24771613
[TBL] [Abstract][Full Text] [Related]
13. Two methods of heterokaryon formation to discover HCV restriction factors.
Frentzen A; Hueging K; Bitzegeio J; Pietschmann T; Steinmann E
J Vis Exp; 2012 Jul; (65):e4029. PubMed ID: 22825033
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic comparison of human hepatoma Huh-7 cell clones with different hepatitis C virus replication efficiencies.
Inoue Y; Murakami K; Hmwe SS; Aizaki H; Suzuki T
Jpn J Infect Dis; 2007 Jul; 60(4):173-8. PubMed ID: 17642525
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C Virus Strain-Dependent Usage of Apolipoprotein E Modulates Assembly Efficiency and Specific Infectivity of Secreted Virions.
Weller R; Hueging K; Brown RJP; Todt D; Joecks S; Vondran FWR; Pietschmann T
J Virol; 2017 Sep; 91(18):. PubMed ID: 28659481
[TBL] [Abstract][Full Text] [Related]
16. Novel HCV replication mouse model using human hepatocellular carcinoma xenografts.
Guévin C; Lamarre A; Labonté P
Antiviral Res; 2009 Oct; 84(1):14-22. PubMed ID: 19622372
[TBL] [Abstract][Full Text] [Related]
17. [In vitro infection of human liver cancer cell line HepG2 with HCV].
Song ZQ; Hao F; Ma QY; Wang YM
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):77-80. PubMed ID: 12870026
[TBL] [Abstract][Full Text] [Related]
18. The hepatitis C virus core protein indirectly induces alpha-smooth muscle actin expression in hepatic stellate cells via interleukin-8.
Clément S; Pascarella S; Conzelmann S; Gonelle-Gispert C; Guilloux K; Negro F
J Hepatol; 2010 May; 52(5):635-43. PubMed ID: 20347177
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the inhibition of hepatitis C virus entry by in vitro-generated and patient-derived oxidized low-density lipoprotein.
Westhaus S; Bankwitz D; Ernst S; Rohrmann K; Wappler I; Agné C; Luchtefeld M; Schieffer B; Sarrazin C; Manns MP; Pietschmann T; Ciesek S; von Hahn T
Hepatology; 2013 May; 57(5):1716-24. PubMed ID: 23212706
[TBL] [Abstract][Full Text] [Related]
20. HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters.
Kasai D; Adachi T; Deng L; Nagano-Fujii M; Sada K; Ikeda M; Kato N; Ide YH; Shoji I; Hotta H
J Hepatol; 2009 May; 50(5):883-94. PubMed ID: 19303158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
